NCT01630668View on ClinicalTrials.gov

Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Hypercholesterolemia
Interventions
DIETARY_SUPPLEMENT

One-a-Day L. reuteri NCIMB 30242 supplement capsule

Once per day, 12 weeks

DIETARY_SUPPLEMENT

One-a-Day placebo capsule

Once per day, 12 weeks

Trial Locations (1)

N6A 5R8

KGK Synergize Inc., London

All Listed Sponsors
lead

Micropharma Limited

INDUSTRY

NCT01630668 - Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule | Biotech Hunter | Biotech Hunter